Cargando…
Insulin initiation and intensification in patients with T2DM for the primary care physician
Type 2 diabetes mellitus (T2DM) is characterized by both insulin resistance and inadequate insulin secretion. All patients with the disease require treatment to achieve and maintain the target glycosylated hemoglobin (A1C) level of 6.5%–7%. Pharmacological management of T2DM typically begins with th...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139533/ https://www.ncbi.nlm.nih.gov/pubmed/21792324 http://dx.doi.org/10.2147/DMSO.S14653 |